 | • レポートコード：MRC2303M087 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：バイオ |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料によると、世界の核酸分離＆精製市場規模が、予測期間中に年平均成長率6.6%で拡大すると予測されています。本書は、核酸分離＆精製の世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、技術別（カラム型精製、磁気ビーズ型精製、試薬型精製）分析、製品別（キット・試薬、機器、その他）分析、用途別（全RNA分離・精製、mRNA分離・精製、microRNA分離・精製、プラスミドDNA分離・精製、その他）分析、エンドユーザー別（病院、学術研究機関、製薬/バイオテクノロジー産業、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Agilent Technologies、Bio-Rad Laboratories Inc.、Thermo Fisher Scientific、BioVision Inc.、Danaher Corporation、F. Hoffmann-La Roche Ltd、GE Healthcare、Merck KGaA (Sigma-Aldrich Corporation)、Promega Corporation、Qiagen NVなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の核酸分離＆精製市場規模：技術別 - カラム型精製の市場規模 - 磁気ビーズ型精製の市場規模 - 試薬型精製の市場規模 ・世界の核酸分離＆精製市場規模：製品別 - キット・試薬の市場規模 - 機器の市場規模 - その他の市場規模 ・世界の核酸分離＆精製市場規模：用途別 - 全RNA分離・精製の市場規模 - mRNA分離・精製の市場規模 - microRNA分離・精製の市場規模 - プラスミドDNA分離・精製の市場規模 - その他の市場規模 ・世界の核酸分離＆精製市場規模：エンドユーザー別 - 病院における市場規模 - 学術研究機関における市場規模 - 製薬/バイオテクノロジー産業における市場規模 - その他における市場規模 ・世界の核酸分離＆精製市場規模：地域別 - 北米の核酸分離＆精製市場規模 アメリカの核酸分離＆精製市場規模 カナダの核酸分離＆精製市場規模 メキシコの核酸分離＆精製市場規模 … - ヨーロッパの核酸分離＆精製市場規模 イギリスの核酸分離＆精製市場規模 フランスの核酸分離＆精製市場規模 ドイツの核酸分離＆精製市場規模 … - アジア太平洋の核酸分離＆精製市場規模 中国の核酸分離＆精製市場規模 インドの核酸分離＆精製市場規模 日本の核酸分離＆精製市場規模 … - 南米/中東の核酸分離＆精製市場規模 ブラジルの核酸分離＆精製市場規模 アルゼンチンの核酸分離＆精製市場規模 南アフリカの核酸分離＆精製市場規模 … - その他地域の核酸分離＆精製市場規模 ・競争状況 ・市場機会・将来の動向 |
The Nucleic Acid Isolation and Purification Market is expected to register a CAGR of 6.6% during the forecast period. growth of the nucleic acid isolation and purification market is due to the rapid technological advancements, wide-range applications of nucleic acid testing in diagnostics, and rise in the R&D funding in biotechnology and healthcare.
Key Highlights
- Nucleic acid has many diagnostic applications in tests of many diseases, such as STDs, congenital anomalies, cancer, etc.
- According to the US Department of Health & Human Services, there were approximately 36.7 million people worldwide living with HIV/AIDS as of 2016. Of these, 2.1 million were children (above 15 years old). The WHO stated that more than 1 million sexually transmitted infections are acquired every day worldwide and 500 million people are estimated to have genital infection with herpes simplex virus (HSV), along with 290 million women who have a human papillomavirus (HPV) infection. Therefore, all STDs can be diagnosed through nucleic acid isolation and identification procedures, and this signifies that the market studied is expected to increase globally.
- The current market is also growing, due to rapid technological advancements, like polymerase chain reaction (the original nucleic acid amplification technique), which transformed the approach of the clinical microbiologists in viewing and using nucleic acid techniques in clinical settings.
Nucleic Acid Isolation & Purification Market Trends
The Equipment Segment is Expected to Hold a Major Market Share in the Nucleic Acid Isolation and Purification Market
- The equipment segment of the market studied is growing at a good pace. There are significant advancements found in the field of molecular diagnostics that have facilitated rapid and continued advancements in nucleic acid isolation and purification technologies, driven by the new knowledge provided by the mapping of genetic risk factors behind many diseases, where lifestyle has an important role to play.
- According to the World Health Organization (WHO) 2020, the alpha and beta thalassaemias are the most common inherited single-gene disorders in the world. The burden of thalassaemias in many regions of the world represents a major public health concern. For example in Iran, it was estimated that each year about 8,000 pregnancies are at risk of this disorder. Moreover, In addition, it was estimated that the incidence of genetic disorder Down syndrome was between 1 in 1,000 to 1 in 1,100 live births worldwide.
- Thus, the high incidence of genetic disorders along with growth in laboratory automation and decreasing changeability may lead to the growth of the equipment segment of the market studied.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
- North America is expected to hold a major market share in the nucleic acid isolation and purification market due to the very high use of downstream processes in the country. The growth of the market is also attributed due to the rapid technological advances, wide-range applications of nucleic acid testing in diagnostics boosting the market, rise in the R&D funding in biotechnology and healthcare.
- According to the Centers for Disease Control and Prevention (CDC), in the United States Hemophilia A affects 1 in 5,000 male births. Each year approximately 400 babies are born with haemophilia A.
- Furthermore, the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Nucleic Acid Isolation & Purification Market Competitor Analysis
The Nucleic Acid Isolation and Purification Market is fragmented competitive and consists of several major players. Some of the recent market trends in the global nucleic acid isolation and purification market are new product development, mergers and acquisition, and partnerships. Agilent Technologies, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Promega Corporation, Qiagen NV, and Thermo Fisher Scientific Inc. are some of the major players in the nucleic acid isolation and purification market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Technological Advancements Boosting the Market Growth
4.2.2 Wide-range Applications of Nucleic Acid Testing in Diagnostics Boosting the Market
4.2.3 Rise in the R&D Funding in Biotechnology and Healthcare
4.3 Market Restraints
4.3.1 Low Penetration in the Emerging Markets
4.3.2 Increasing Cost of Automated Instruments
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Column-based Purification
5.1.2 Magnetic Bead-based Purification
5.1.3 Reagent-based Purification
5.2 By Product
5.2.1 Kits and Reagents
5.2.2 Equipment
5.2.3 Other Products
5.3 By Application
5.3.1 Total RNA Isolation and Purification
5.3.2 mRNA Isolation and Purification
5.3.3 microRNA Isolation and Purification
5.3.4 Plasmid DNA Isolation and Purification
5.3.5 Genomic DNA Isolation and Purification
5.3.6 Blood DNA Isolation and Purification
5.3.7 PCR Clean-up
5.3.8 Other Nucleic Acid Isolation and Purification Applications
5.4 By End User
5.4.1 Hospitals
5.4.2 Academic and Research Institutes
5.4.3 Pharmaceutical/Biotechnology Industry
5.4.4 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 Thermo Fisher Scientific
6.1.4 BioVision Inc.
6.1.5 Danaher Corporation
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 GE Healthcare
6.1.8 Merck KGaA (Sigma-Aldrich Corporation)
6.1.9 Promega Corporation
6.1.10 Qiagen NV
7 MARKET OPPORTUNITIES AND FUTURE TRENDS